NR3C2 and cardiac hypertrophy: Our new data indicate that deletion of EC‐MR does not affect systolic function during homeostasis, but contributes to the development of systolic dysfunction in response to TAC without modulating cardiac hypertrophy, fibrosis, or diastolic function.